However, the court ruled that a dosing regimen for a Janssen Inc. schizophrenia drug is patentable
Jul 17, 2026
Jul 17, 2026
Every month, Canadian Lawyer will produce a series of articles on a theme affecting the legal profession. All coverage through the month can be found here
Jul 17, 2026
STEM director created works under consulting agreement with company that stopped paying him
Jul 15, 2026
In proceeding brought by BLG, registration maintained for services that used mark in relevant period
Jul 14, 2026
As federal spending surges, intellectual property strategy is a key risk for Canadian companies
Jul 10, 2026
Ruling finds novel issue on company’s standing as licensee and status as plaintiff
